- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05013359
Awareness, Care & Treatment In Obesity Management - An International Observation Among Teens (ACTION Teens) (ACTION Teens)
ACTION Teens is a multinational cross-sectional survey-based study. The study consists of a quantitative online survey to be conducted among three groups of respondents in ten countries worldwide. The respondent population will include Adolescents Living with Obesity (ALwO), Caregivers of ALwO, and HCPs treating adolescents who have obesity.
The goal of this study is to provide insights to drive awareness around the needs of adolescents living with obesity and their caregivers, as well as to identify key areas of misalignment between adolescents, their caregivers and the HCPs involved in obesity treatment and management. ACTION Teens is designed to generate evidence to identify and address these challenges on both a global and local level, extending the insights from the previously conducted ACTION-IO study.
Study Overview
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Sydney, Australia, NSW 2060
- Novo Nordisk Investigational Site
-
-
-
-
-
Bogotá, Colombia, 110111
- Novo Nordisk Investigational Site
-
-
-
-
-
Rome, Italy, 00144
- Novo Nordisk Investigational Site
-
-
-
-
-
Seoul, Korea, Republic of, 05510
- Novo Nordisk Investigational Site
-
-
-
-
-
Mexico City, Mexico, 11560
- Novo Nordisk Investigational Site
-
-
-
-
-
Riyadh, Saudi Arabia, 13315
- Novo Nordisk Investigational Site
-
-
-
-
-
Madrid, Spain, 28033
- Novo Nordisk Investigational Site
-
-
-
-
-
Taipei, Taiwan, 106
- Novo Nordisk Investigational Site
-
-
-
-
-
Istanbul, Turkey, 34335
- Novo Nordisk Investigational Site
-
-
-
-
-
Gatwick, United Kingdom, RH6 0PA
- Novo Nordisk Investigational Site
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria for Adolescents living with obesity:
- Informed consent obtained by parent/legal guardian and ALwO before any study-related activities (study-related activities are any procedure related to recording of data according to the protocol).
- Male or female, aged 12 to less than 18 years at the time of signing informed consent.
- Lives in one of the participating countries: Italy, Spain, UK, Mexico, Colombia, Australia, Saudi Arabia, Turkey, South Korea, and Taiwan.
- Has a current BMI-for-age (based on self-reported sex, age, height, and weight) greater than or equal to 95th percentile for age and sex based on charts appropriate locally for the country of residence.
Inclusion Criteria for Caregivers of Adolescents living with obesity:
- Informed consent before any study-related activities (study-related activities are any procedure related to recording of data according to the protocol).
- Male or female, age above or equal to 24 years at the time of signing informed consent.
- Lives in one of the participating countries: Italy, Spain, UK, Mexico, Colombia, Australia, Saudi Arabia, Turkey, South Korea, and Taiwan.
- Has an adolescent in the household with a current BMI-for-age (based on self-reported sex, age, height, and weight) greater than or equal to 95th percentile for age and sex based on charts appropriate locally for the country of residence.
- Resides in the same household as the ALwO at least 50% of the time.
- Is involved in the healthcare decisions of the ALwO.
Inclusion Criteria for Health Care Providers:
- Informed consent before any study-related activities (study-related activities are any procedure related to recording of data according to the protocol).
- Male or female, age above or equal to 18 years at the time of signing informed consent.
- Is a physician.
- Practices in one of the participating countries: Italy, Spain, UK, Mexico, Colombia, Australia, Saudi Arabia, Turkey, South Korea, and Taiwan
- In clinical practice more than or equal to 2 years.
- Spends at least 50% of time in direct patient care.
- Has seen/treated at least ten adolescent patients (age 12 to less than 18 years) with obesity in a typical month (defined as BMI-for-age greater than or equal to 95th percentile for age and sex based on charts appropriate locally for the country of residence).
Exclusion Criteria for Adolescents living with obesity:
- Previous participation in this study. Participation is defined as having given informed consent in this study.
- Mental incapacity, unwillingness, inability, or language barriers precluding adequate understanding or cooperation.
- Has had significant weight loss or weight gain due to major injury or illness/condition (e.g., cancer, accident, pregnancy) in the past 6 months.
- Considers themselves to be extremely muscular.
Exclusion Criteria for Caregivers of Adolescents living with obesity:
- Previous participation in this study. Participation is defined as having given informed consent in this study.
- Mental incapacity, unwillingness, inability, or language barriers precluding adequate understanding or cooperation.
- ALwO they care for has had significant weight loss or weight gain due to major injury or illness/condition (e.g., cancer, accident, pregnancy) in the past 6 months.
- Considers the ALwO they care for to be extremely muscular.
Exclusion Criteria for Health Care Providers:
- Previous participation in this study. Participation is defined as having given informed consent in this study.
- Mental incapacity, unwillingness, inability, or language barriers precluding adequate understanding or cooperation.
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Adolescents Living with Obesity (ALwO)
Recruited from online, general population consumer panels
|
No treatment given
|
|
Health Care Providers (HCPs)
HCPs treating adolescents who have obesity
|
No treatment given
|
|
Caregivers
A parent or legal guardian of an adolescent with obesity
|
No treatment given
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Attitudes about obesity, attitudes about people with obesity, and beliefs about the impact of obesity
Time Frame: At the time of survey response (Day 1)
|
5-point Likert scales (e.g., agreement, impact, frequency) - Proportion of responses in each category will be reported. |
At the time of survey response (Day 1)
|
|
Weight loss attempts in past year, motivations to lose weight, barriers to losing weight, and definition of successful weight loss/management
Time Frame: At the time of survey response (Day 1)
|
Yes/No; percentage of participants Multi-select from defined list - Percentage of respondents selecting an item or items will be reported. |
At the time of survey response (Day 1)
|
|
History and frequency of conversations about weight, initiator of weight conversations, and responsibility for initiating weight conversations that occur between adolescents living with obesity/their caregivers and healthcare providers
Time Frame: At the time of survey response (Day 1)
|
Numeric entry; percentage of participants Single select from defined list; percentage of time each initiates Single select from defined list
|
At the time of survey response (Day 1)
|
|
Assessment of interactions between adolescents living with obesity/their caregivers and healthcare providers, reasons why obesity may not be discussed, frequency of obesity diagnosis, and frequency of follow-up appointments made to discuss obesity
Time Frame: At the time of survey response (Day 1)
|
5-point Likert scales Multi-select from defined list Yes/No; percentage of patients Yes/No; percentage of patients
|
At the time of survey response (Day 1)
|
|
Sources of information used to learn about obesity, healthy lifestyles, weight loss, and weight management
Time Frame: At the time of survey response (Day 1)
|
Multi-select from defined list
|
At the time of survey response (Day 1)
|
Collaborators and Investigators
Sponsor
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- DAS-003
- U1111-1262-1190 (Other Identifier: World Health Organization)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Obesity
-
Dr. Christopher McGowanRecruitingObesity Prevention | Obesity Recidivism | Obesity and Overweight | Obesity and Obesity-related Medical ConditionsUnited States
-
Central Hospital, Nancy, FranceNot yet recruiting
-
Helsinki University Central HospitalKarolinska Institutet; Folkhälsan Researech CenterEnrolling by invitation
-
Istanbul Medipol University HospitalMedipol UniversityCompletedObesity, Morbid | Obesity, Adolescent | Obesity, Abdominal | Weight, Body | Obesity, VisceralTurkey
-
Dr. Christopher McGowanRecruitingObesity Prevention | Obesity Recidivism | Obesity and Overweight | GLP-1 | Obesity and Obesity-related Medical Conditions | Ablation TechniquesUnited States
-
Azienda Ospedaliero-Universitaria Consorziale Policlinico...Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies; Istituti... and other collaboratorsCompletedMorbid Obesity | Metabolically Healthy ObesityItaly
-
Queen Fabiola Children's University HospitalNot yet recruitingMorbid Obesity | Adolescent Obesity | Bariatric SurgeryBelgium
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; Pennington Biomedical Research... and other collaboratorsCompletedOvernutrition | Nutrition Disorders | Overweight | Body Weight | Pediatric Obesity | Body Weight Changes | Childhood Obesity | Weight Gain | Adolescent Obesity | Obesity, Childhood | Overweight and Obesity | Overweight or Obesity | Overweight AdolescentsUnited States
-
The Hospital for Sick ChildrenCompleted
-
Ihuoma EneliCompletedObesity, ChildhoodUnited States
Clinical Trials on No treatment given
-
Novo Nordisk A/SNot yet recruiting
-
Robert G. Grossman, MDThe University of Texas Health Science Center, Houston; University of Maryland... and other collaboratorsRecruitingSpinal Cord InjuryUnited States, Canada
-
Novo Nordisk A/SCompletedObesity | Overweight | Primary Prevention | Heart Failure (HF) | Atherosclerotic Cardiovascular Disease (ASCVD)United States
-
Novo Nordisk A/SCompleted
-
Novo Nordisk A/SEnrolling by invitationParkinson DiseaseUnited States, Japan, Sweden, United Kingdom
-
Novo Nordisk A/SCompletedChronic Kidney Disease (CKD) | Atherosclerotic Cardiovascular Disease (ASCVD)China
-
Novo Nordisk A/SEnrolling by invitation
-
Novo Nordisk A/SCompleted
-
Novo Nordisk A/SCompletedHeart Failure | Chronic Kidney Disease | Cardiovascular RiskKorea, Republic of, Italy, China, France, Canada, Sweden, India, Denmark, Czechia, Germany, Poland, Australia, Brazil, United States, Argentina, Norway, United Kingdom
-
Novo Nordisk A/SCompleted